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The goal of the present study was to examine the 
transmission dynamics of multidrug-resistant tuber-
culosis (MDR-TB) in Switzerland. Between 2006 and 
2012, a total of 49 MDR-TB cases were reported to 
the Swiss Federal Office of Public Health, 46 of which 
were of foreign origin. All 49 initial strains were evalu-
ated by molecular epidemiologic methods at the Swiss 
National Reference Centre for Mycobacteria. In 43 
strains, unique DNA fingerprint patterns were identi-
fied. Twelve strains were grouped into six clusters. 
Data from contact tracing suggest likely in-country 
transmission in four clusters, mostly among close 
contacts. In the remaining two clusters, no contact 
tracing data were available, but the identified geno-
types were known to be prevalent in the countries of 
origin of the patients, suggesting the possibility that 
the infection was acquired there. While most MDR-TB 
cases are imported to Switzerland, at least four of the 
49 MDR-TB cases were due to transmission within the 
country. The imported cases, however, did not lead to 
secondary cases outside the circles of close contacts. 
The results also indicate that prevention of MDR-TB 
transmission among immigrants may require closer 
monitoring.
Introduction
One of the most challenging concerns in tuberculosis 
control programmes, both in high and low-prevalence 
settings, is the emergence and transmission of mul-
tidrug-resistant tuberculosis (MDR-TB), by definition 
resistant at least to isoniazid and rifampicin [1]. The 
World Health Organization estimates 450,000 cases 
of MDR-TB to have occurred in 2012 worldwide, corre-
sponding to 5.2% of all TB cases [2]. In Switzerland, 
the incidence of TB decreased steadily over many dec-
ades and seems to have reached a plateau in recent 
years at 7.0 per 100,000 population [3]. In the period 
2005 to 2011, 71% of all TB cases in Switzerland were 
foreign-born. The proportion of culture-positive cases 
was 82.2% (3,093 of 3,763 cases) and 3,069 of the 
3,093 culture-positive cases had susceptibility testing 
results, of which 47 (1.5%) had MDR-TB [3]. 
The goal of the present study was to analyse the trans-
mission dynamics of MDR-TB in Switzerland by examin-
ing all MDR-TB strains identified in the country over a 
seven-year period using molecular methods and con-
tact investigations in clustered cases. 
Methods
Since 1997, all laboratories in Switzerland have been 
submitting MDR-TB strains isolated in the country 
to the National Reference Centre for Mycobacteria 
(NZM). Cases were defined as MDR-TB when the iso-
late was resistant to at least isoniazid at 1.0 mg/mL 
and rifampicin at 1.0mg/mL in the MGIT 960 system 
(Becton, Dickinson and Company) [4]. In the present 
study, we examined all initial MDR-TB isolates submit-
ted to the NZM between January 2006 and December 
2012. All strains (one strain per patient) were charac-
terised by extensive conventional and molecular drug 
susceptibility testing as described earlier [4]. All iso-
lates were also evaluated by IS6110 DNA restriction 
fragment length polymorphism (RFLP) fingerprint-
ing, spoligotyping and 24-locus mycobacterial inter-
spersed repetitive unit-variable number tandem repeat 
(MIRU-VNTR) as described previously [5-8]. Clusters 
were defined as groups of at least two patients with 
Mycobacterium tuberculosis strains showing identical 
IS6110 RFLP (same number of IS6110 bands at identi-
cal positions, position tolerance 1.2%), spoligotype 
and MIRU-VNTR patterns [7,8]. Baseline epidemiologi-
cal data were obtained from the Swiss Federal Office 
of Public Health). Contact tracing was conducted by 
the local health authorities of the respective can-
tons. Results of the contact investigations were made 
available by the Lung Associations of Zurich and Bern 
(‘Lunge Zürich’ and ‘Lungenliga Bern’) acting on behalf 
of the respective health authorities. 
Results
Between 2006 and 2012, a total of 49 cases of MDR-TB 
were reported to the national surveillance system. 
None of the strains were extensively drug-resistant 
(XDR) isolates.  Initial isolates of all these patients 
were submitted to the reference laboratory. Forty-six 
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Figure
IS6110 fingerprint patterns of the 49 patients identified with multidrug-resistant tuberculosis and the 12 individuals in six 
clusters with identical fingerprints, Switzerland, 2006 and 2012 (n=49)
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Blue: Clusters of patients with direct contact; red: clusters of patients for whom transmission in Switzerland is not probable.
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patients were foreign-born and/or of foreign national-
ity. Of the three Swiss nationals, one had been living in 
Thailand and one was the teenage child of an MDR-TB 
patient born in sub-Saharan Africa, while no signifi-
cant information could be identified on the exposure of 
the third individual.
Altogether, we identified 43 different DNA fingerprint 
patterns. Twelve of the 49 strains were grouped in six 
clusters with identical fingerprints, while 37 patients 
had individual fingerprints (Figure). Contact investi-
gations of clustered patients confirmed epidemiologi-
cal links in four clusters (Figure, highlighted in blue). 
First- and second-line drug susceptibility patterns were 
identical in all four clusters. All source cases of the four 
clusters were sputum smear-positive. In the remain-
ing two clusters, the closest epidemiological link that 
could be confirmed was the geographical origin.
In the first cluster, the transmission event was identi-
fied among Tibetan immigrants and was from an adult 
to a child of pre-school age born in Switzerland. The 
source case was a friend of the family who regularly 
met and supervised the child. The primary contact 
investigation of the index case had not pointed to the 
child, who was diagnosed 10 months later and died of 
TB meningitis while under standard first-line treatment 
awaiting drug susceptibility testing results. 
In the second cluster, transmission also occurred 
in Tibetan immigrants who were living together in 
Switzerland and had not met before their arrival to the 
country. Four weeks after the identification of the index 
case, asymptomatic active disease was detected radio-
logically in the contact during the contact investigation. 
The third cluster was most likely the result of transmis-
sion between two immigrants from Turkey and Kosovo 
attending the same language school for several hours 
a day over many weeks. In this cluster, the contact 
tested tuberculin-negative eight weeks after the last 
exposure, but became symptomatic with pulmonary TB 
three years later. 
The fourth cluster was due to transmission from a 
parent to their teenage child. The index patient had 
immigrated from Sub-Saharan Africa to Switzerland 
14 years earlier. Pulmonary TB was identified in the 
asymptomatic child during the contact investigation.
The fifth molecular cluster consisted of two Ethiopians. 
One case was diagnosed with spinal TB one year 
before the second case was diagnosed with pulmonary 
TB and unknown sputum smear status. The contact 
investigation of the pulmonary case did not establish 
an epidemiological link and the investigation could not 
be re-opened for further investigations by the time the 
molecular epidemiological results became available. 
The sixth cluster consisted of two patients from Ukraine 
and Estonia, diagnosed in 2007 and 2011: a tourist and 
an asylum seeker, respectively, with different resist-
ance profiles. Both patients could not be located any 
more for initiation of treatment. No additional data of 
contact tracing are available. 
Molecular epidemiological testing of the fifth and 
sixth cluster (Figure, highlighted in red) showed the 
presence of strains with genotypes that were highly 
prevalent in the home countries of these patients: the 
ill-defined T family in Cluster 5, and the Beijing geno-
type in Cluster 6 [8,9].
Thus, at least four secondary cases (Clusters 1 to 4, 
highlighted in blue in Figure) were due to transmission 
within Switzerland during the examined period, corre-
sponding to 8% of all MDR-TB cases in the country.
Discussion
This report is providing molecular epidemiological 
insight into the transmission dynamics of MDR-TB 
in a low-incidence setting over a seven-year period. 
We have identified clustering in a quarter of the 
49 MDR-TB strains that represent all MDR-TB cases 
reported nationwide in the period from 2006 to 2012. 
Transmission leading to secondary cases was con-
firmed by conventional contact tracing in four of the 49 
cases. Transmission occurred mainly among persons 
living together or otherwise spending significant time 
together in a closed room on a regular basis over sev-
eral weeks. 
Comparable studies have been carried out in other 
resource-rich, low-incidence settings with similar pop-
ulation sizes and with a majority of TB cases occurring 
in immigrants (Table). A similar proportion of cases 
with recent transmission (7%; 2 of 29 MDR-TB cases) 
was found in Denmark over the period from 1992 to 
2007 [10]. In a long-term and prospective follow-up 
of contacts exposed to MDR-TB patients in Victoria, 
Australia, the transmission rate was 5% (2 of 40 cases) 
in the period from 2002 to 2010 [11]. However, in a 
study in Galicia in the period from 1998 to 2004, with 
the vast majority of MDR-TB patients of Spanish ori-
gin, 53% of MDR-TB patients (30 of 57) were grouped 
in four clusters [12]. Unfortunately, drug susceptibility 
testing was not performed routinely on all clinical iso-
lates in the latter study so that only about half of the 
MDR-TB cases estimated to have occurred were iden-
tified, thus possibly overestimating the proportion of 
clustering. Approximately half of the clustered cases 
could be attributed to recent transmission (two proba-
ble outbreaks, one of them nosocomial among patients 
and healthcare workers) [11]. In a German study rep-
resenting an estimated 75% of all MDR strains occur-
ring country-wide in 1995 to 2001, the rate of clustered 
MDR-TB cases was reported to be 49.4% (214 of 433 
patients) [13]. Epidemiological links were established 
among 18.2% of the clustered patients (39 of 214), 
which corresponds to a proportion of cases with recent 
transmission of 5.8% (25 of 433). Taken together, these 
findings demonstrate that confirmed transmission of 
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MDR-TB with subsequent progression to disease is 
not infrequent in settings with low incidence and with 
cases predominantly in immigrants. 
MDR-TB may or may not differ from drug-susceptible 
TB in terms of transmissibility. At present, the effects 
of drug resistance on transmission of tuberculosis are 
only partly understood. On the one hand, delays in 
initiating adequate therapy may prolong infectious-
ness of a patient. On the other hand, drug resistance-
associated mutations may lead to reduced fitness 
of the bacterium, which may decrease the chance of 
transmission [14-16]. As in other studies in small geo-
graphical areas with large proportions of patients from 
elsewhere, some of the contacts in our study may have 
remained in the area only for a limited period of time. 
This reduces the chances of the contact still being in 
the area, or in the country, when signs of active dis-
ease develop. Our study may thus underestimate the 
true extent of onward transmission particularly in 
population groups in which social contacts tend to be 
limited to fellow migrants. However, our results that 
all confirmed MDR-TB transmissions were identified in 
immigrants are in line with findings of a recent system-
atic review which found that transmission of TB from 
foreign-born patients does not have a significant influ-
ence on the TB situation in native-born populations in 
the European Union or European Economic Area [17]. A 
further limitation is that seven years of observation is 
a short time, seeing as cluster studies tend to under-
estimate clustering at the beginning and at the end 
of the study period, when source cases or secondary 
cases, respectively, are not included. The strength of 
our study is the completeness of the dataset, as all 
microbiologically confirmed MDR-TB cases of the coun-
try were assessed. 
In conclusion, our findings show that considerable 
transmission of MDR-TB, leading to secondary cases, 
occurred in Switzerland between 2006 and 2012. 
However, our estimated transmission rate of 8% may 
be an underestimate of the true situation because 
the majority of MDR-TB cases were detected among 
immigrants and their foreign contacts, who often leave 
the country before active disease develops. Our study 
also indicates that prevention of MDR-TB transmission 
among immigrants may warrant closer monitoring. 
Since treatment and management of each MDR-TB case 
may be complicated with uncertain outcomes, appro-
priate measures and structures must be in place so 
that cases can be handled adequately and timely, and 
transmission can be prevented.
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